Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
2014; Springer Nature; Volume: 4; Issue: 2 Linguagem: Inglês
10.1038/bcj.2014.9
ISSN2044-5385
AutoresParaskevi Miltiades, Eleftheria Lamprianidou, T. P. Vassilakopoulos, Sotirios G. Papageorgiou, Athanasios Galanopoulos, Sofia Vakalopoulou, Vassilia Garypidou, Maria Papaioannou, Evdoxia Hadjiharissi, Vasiliki Pappa, Helen Α. Papadaki, Emmanuel Spanoudakis, Konstantinos Tsatalas, Ιoannis Kotsianidis,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoExpression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
Referência(s)